CalciMedica, Inc. (CALC) Form 8-K — Aug 19, 2026
$CALCForm 8-KItems 5.02, 5.07, 9.01Filed Aug 19, 2026, 6:36 PM ET0001193125-26-357258Original filing
CalciMedica stockholders, at the company's 2026 annual meeting held August 19, 2026, approved all eight proposals, including authority for the Board to effect a reverse stock split at a ratio in the range of 1-for-2 to 1-for-10, with the final ratio and timing left to the Board's sole discretion.
Key figures
- Shares Outstanding
- 30736401
- Record date
- July 21, 2026
- Annual automatic increase
- 5% per year each January 1, 2027 through 2033
- Reverse split ratio range
- 1-for-2 to 1-for-10
- Equity plan share increase
- 7500000
- Iso aggregate limit shares
- 37001070
- Non employee director comp cap
- $750,000 per year ($1,000,000 first year)
- Record date shares outstanding
- 30736401
- Equity plan total share reserve
- 12333690
- Series a warrant underlying shares
- 18673429
- Series b warrant underlying shares
- 18673429
- Director officer warrant shares per series
- 1680565
Price after filing
1 day: -4.9%7 days: -4.2%30 days: -35.7%
Close on the filing date to close N calendar days later (from $3.07). Historical, not a forecast.
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.